Ding Yun-Shen, Wang Yi-Han, Liu Feng
Department of Urology, The Sixth People's Hospital South Campus Affiliated to Shanghai Jiaotong University, Shanghai, China.
Urol Case Rep. 2025 Jan 29;59:102965. doi: 10.1016/j.eucr.2025.102965. eCollection 2025 Mar.
To optimize the diagnosis and treatment of Tubulocystic renal cell carcinoma, we present our experience with a case of it and review the literature. Tubulocystic renal cell carcinoma (TRCC) is a rare subtype of renal carcinoma with distinctive histological and molecular characteristics. This study provides a comprehensive analysis of TRCC, focusing on its pathological features, diagnostic criteria, and potential molecular mechanisms. The findings highlight the unique histological architecture and biological behavior of TRCC, distinguishing it from other renal cell carcinomas. Advanced imaging techniques and molecular biomarkers play a pivotal role in its accurate diagnosis.
为优化肾小管囊性肾细胞癌的诊断和治疗，我们介绍一例该疾病的诊治经验并回顾相关文献。肾小管囊性肾细胞癌（TRCC）是一种罕见的肾癌亚型，具有独特的组织学和分子特征。本研究对TRCC进行了全面分析，重点关注其病理特征、诊断标准和潜在分子机制。研究结果突出了TRCC独特的组织结构和生物学行为，使其有别于其他肾细胞癌。先进的成像技术和分子生物标志物在其准确诊断中发挥着关键作用。
